ANAPLASTIC LARGE CELL LYMPHOMA
Clinical trials for ANAPLASTIC LARGE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC LARGE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC LARGE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test drug duo in fight against deadly blood cancer
Disease control Not yet recruitingThis is an early-stage trial to see if combining two existing drugs, azacitidine and abatacept, is safe and can shrink tumors in people with T-cell lymphoma that has come back or not responded to prior treatment. The study will involve about 20 adults to find the right dose and s…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Scientists dig deep into lymphoma tumors to predict treatment success
Knowledge-focused Not yet recruitingThis study aims to understand how well a recently approved drug combination works for a rare blood cancer in real-world patients, not just in a controlled trial. Researchers will look back at the health records of 100 patients already treated with this drug and analyze their stor…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC